BridgeMD
New treatment option for Non-steroidal Anti-inflammatory Drugs
Official title Non-steroidal Anti-inflammatory Drugs in Pleurodesis
ClinicalTrials.gov ID: NCT06731647
What this study is testing
What is KETOPROFEN(RP19583)?
KETOPROFEN(RP19583) is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for non-steroidal anti-inflammatory drugs.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended in a multimodal pain management to reduce pain intensity and to spare opioid use. However, there is a controversy in its use in pleurodesis surgery as it could block the process of pleurodesis in surgical pneumothorax.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age≥18-year-old
- pneumothorax with an indication of pleurodesis
- with or without minimal lung resection
- via thoracotomy or thoracoscopy
You likely can't join if
- Minor patient
- Pregnant, parturient or breast-feeding patient
- Severe polytrauma (associated with the presence of a Vittel criterion)
- Purulent pleurisy
- Hemopneumothorax
- Lactose hyper sensibility
See the full eligibility criteria
- Age≥18-year-old
- pneumothorax with an indication of pleurodesis
- with or without minimal lung resection
- via thoracotomy or thoracoscopy
- Minor patient
- Pregnant, parturient or breast-feeding patient
- Severe polytrauma (associated with the presence of a Vittel criterion)
- Purulent pleurisy
- Hemopneumothorax
- Lactose hyper sensibility
- Contraindications to NSAID
- Contraindications to tramadol
- Contraindications to paracetamol
- Curative anticoagulation
- Patients under guardians or deprived of their liberty
- Patient refusal
The study team makes the final eligibility decision.
Where it's taking place
- Amiens, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amiens, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.